Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Breno S. O. Diniz, Jony A. Pinto$suffix/text()$suffix/text() & Orestes Vicente Forlenza. (2008) Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. The World Journal of Biological Psychiatry 9:3, pages 172-182.
Read now
Read now
Kaj Blennow. (2005) CSF biomarkers for Alzheimer’s disease: use in early diagnosis and evaluation of drug treatment. Expert Review of Molecular Diagnostics 5:5, pages 661-672.
Read now
Read now
David Salmon & JohnR. Hodges. (2005) Introduction: Mild cognitive impairment—cognitive, behavioral, and biological factors. Neurocase 11:1, pages 1-2.
Read now
Read now
Articles from other publishers (32)
Brenda Chino, Lucía Torres-Simón, Agnieszka Żelwetro, Inmaculada Concepción Rodríguez-Rojo, Anna Carnes-Vendrell, Gerard Piñol-Ripoll, Raquel Yubero, Nuria Paúl & Fernando Maestú. (2023) Understanding the Episodic Memory and Executive Functioning Axis Impairment in MCI Patients: A Multicenter Study in Comparison with CSF Biomarkers. Biomedicines 11:12, pages 3147.
Crossref
Crossref
Vasileios Papaliagkas, Kallirhoe Kalinderi, Patroklos Vareltzis, Despoina Moraitou, Theodora Papamitsou & Maria Chatzidimitriou. (2023) CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease. International Journal of Molecular Sciences 24:10, pages 8976.
Crossref
Crossref
Greta García-Escobar, Albert Puig-Pijoan, Víctor Puente-Periz, Aida Fernández-Lebrero, Rosa María Manero, Irene Navalpotro-Gómez, Marc Suárez-Calvet, Oriol Grau-Rivera, José Contador-Muñana, Diego Cascales-Lahoz, Xavier Duran-Jordà, Núncia Boltes, Maria Claustre Pont-Sunyer, Jordi Ortiz-Gil, Sara Carrillo-Molina, María Dolores López-Villegas, María Teresa Abellán-Vidal, María Isabel Martínez-Casamitjana, Juan José Hernández-Sánchez, Anna Padrós-Fluvià, Jordi Peña-Casanova & Gonzalo Sánchez-Benavides. (2023) NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer’s Disease. Journal of Alzheimer's Disease 92:4, pages 1303-1321.
Crossref
Crossref
Louisien Lebrun, Bernard Hanseeuw, Vincent van Pesch & Adrian Ivanoiu. (2022) Alzheimer disease’s cerebrospinal fluid biomarkers differences between immigrants and natives in a Belgian memory clinic. Acta Neurologica Belgica 123:2, pages 537-544.
Crossref
Crossref
Brenda Chino-Vilca, Inmaculada Concepción Rodríguez-Rojo, Lucía Torres-Simón, Pablo Cuesta, Anna Carnes Vendrell, Gerard Piñol-Ripoll, Raquel Huerto, Nuria Tahan & Fernando Maestú. (2022) Sex specific EEG signatures associated with cerebrospinal fluid biomarkers in mild cognitive impairment. Clinical Neurophysiology 142, pages 190-198.
Crossref
Crossref
Katherine A. Gifford, Dandan Liu, Jacquelyn E. Neal, Michelle A. Babicz, Jennifer L. Thompson, Lily E. Walljasper, Margaret E. Wiggins, Maxim Turchan, Kimberly R. Pechman, Katie E. Osborn, Lealani Mae Y. Acosta, Susan P. Bell, Timothy J. Hohman, David J. Libon, Kaj Blennow, Henrik Zetterberg & Angela L. Jefferson. (2018) The 12-Word Philadelphia Verbal Learning Test Performances in Older Adults: Brain MRI and Cerebrospinal Fluid Correlates and Regression-Based Normative Data. Dementia and Geriatric Cognitive Disorders Extra 8:3, pages 476-491.
Crossref
Crossref
Mitzi M. Gonzales, Philip S. Insel, Craig Nelson, Duygu Tosun, Michael Schöll, Niklas Mattsson, Simona Sacuiu, David Bickford, Michael W. Weiner & R. Scott Mackin. (2018) Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment. International Journal of Geriatric Psychiatry 33:10, pages 1305-1311.
Crossref
Crossref
Babette L.R. Reijs, Inez H.G.B. Ramakers, Sebastian Köhler, Charlotte E. Teunissen, Marleen Koel-Simmelink, Pradeep J. Nathan, Magda Tsolaki, Lars-Olof Wahlund, Gunhild Waldemar, Lucrezia Hausner, Rik Vandenberghe, Peter Johannsen, Andrew Blackwell, Hugo Vanderstichele, Frans Verhey & Pieter Jelle Visser. (2017) Memory Correlates of Alzheimer’s Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study. Journal of Alzheimer's Disease 60:3, pages 1119-1128.
Crossref
Crossref
Craig Ritchie, Nadja Smailagic, Anna H Noel-Storr, Obioha Ukoumunne, Emma C Ladds & Steven Martin. (2017) CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews 2017:3.
Crossref
Crossref
Eric E. Brown, Yusuke Iwata, Jun Ku Chung, Philip Gerretsen & Ariel Graff-Guerrero. (2016) Tau in Late-Life Depression: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease 54:2, pages 615-633.
Crossref
Crossref
O. S. Cohen, J. Chapman, A. D. Korczyn, N. Warman-Alaluf, Z. Nitsan, S. Appel, E. Kahana & H. Rosenmann. (2016) CSF tau correlates with CJD disease severity and cognitive decline. Acta Neurologica Scandinavica 133:2, pages 119-123.
Crossref
Crossref
Michael Guhra, Christine Thomas, Sebastian Boedeker, Stefan Kreisel, Martin Driessen, Thomas Beblo, Patricia Ohrmann & Max Toepper. (2016) Linking CSF and cognition in Alzheimer's disease: Reanalysis of clinical data. Experimental Gerontology 73, pages 107-113.
Crossref
Crossref
Craig Ritchie, Nadja Smailagic, Anna H Noel-Storr, Yemisi Takwoingi, Leon Flicker, Sam E Mason & Rupert McShane. (2014) Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ramune Grambaite, Erik Hessen, Eirik Auning, Dag Aarsland, Per Selnes & Tormod Fladby. (2013) Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers. Dementia and Geriatric Cognitive Disorders Extra 3:1, pages 291-300.
Crossref
Crossref
Mark S. Henry, Anthony P. Passmore, Stephen Todd, Bernadette McGuinness, David Craig & Janet A. Johnston. (2012) The development of effective biomarkers for Alzheimer's disease: a review. International Journal of Geriatric Psychiatry 28:4, pages 331-340.
Crossref
Crossref
Valerie C. Cullen, Ross A. Fredenburg, Cindy Evans, Phyllis R. Conliffe & Michael E. Solomon. (2012) Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid. The AAPS Journal 14:3, pages 510-518.
Crossref
Crossref
Hanna Rosenmann. (2011) CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease. Journal of Molecular Neuroscience 47:1, pages 1-14.
Crossref
Crossref
M. WagnerS. WolfF.M. ReischiesM. DaerrS. WolfsgruberF. JessenJ. PoppW. MaierM. HüllL. FrölichH. HampelR. PerneczkyO. PetersH. JahnC. LuckhausH.-J. GertzJ. SchröderJ. PantelP. LewczukJ. KornhuberJ. Wiltfang. (2012) Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology 78:6, pages 379-386.
Crossref
Crossref
Petra E. Spies, Jurgen A.H.R. Claassen, Diane Slats, Marcel G.M. Olde Rikkert, Marcel M. Verbeek & Roy P.C. Kessels. (2014) Cerebrospinal Fluid Tau and Amyloid β Proteins Do Not Correlate With Cognitive Functioning in Cognitively Impaired Memory Clinic Patients. CNS Spectrums 15:9, pages 588-593.
Crossref
Crossref
Hyman M. Schipper. (2010) Biological Markers and Alzheimer Disease: A Canadian Perspective. International Journal of Alzheimer's Disease 2010, pages 1-7.
Crossref
Crossref
A. E. van der VliesN. A. VerweyF. H. BouwmanM. A. BlankensteinM. KleinP. ScheltensW. M. van der Flier. (2009) CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. Neurology 72:12, pages 1056-1061.
Crossref
Crossref
C. Haense, K. Buerger, E. Kalbe, A. Drzezga, S. J. Teipel, P. Markiewicz, K. Herholz, W. D. Heiss & H. Hampel. (2008) CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease. European Journal of Neurology 15:11, pages 1155-1162.
Crossref
Crossref
ARTO NORDLUND, SINDRE ROLSTAD, OLA KLANG, KARIN LIND, MONA PEDERSEN, KAJ BLENNOW, ÅKE EDMAN, STEFAN HANSEN & ANDERS WALLIN. (2008) Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI. Journal of the International Neuropsychological Society 14:4, pages 582-590.
Crossref
Crossref
A.M. Fjell, K.B. Walhovd, I. Amlien, A. Bjørnerud, I. Reinvang, L. Gjerstad, T. Cappelen, F. Willoch, P. Due-Tønnessen, R. Grambaite, A. Skinningsrud, V. Stenset & T. Fladby. (2008) Morphometric Changes in the Episodic Memory Network and Tau Pathologic Features Correlate with Memory Performance in Patients with Mild Cognitive Impairment. American Journal of Neuroradiology 29:6, pages 1183-1189.
Crossref
Crossref
R. Ceravolo, D. Borghetti, L. Kiferle, G. Tognoni, A. Giorgetti, D. Neglia, N. Sassi, D. Frosini, C. Rossi, L. Petrozzi, G. Siciliano & L. Murri. (2008) CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease. Brain Research Bulletin 76:1-2, pages 80-84.
Crossref
Crossref
Hyman M. Schipper. (2007) The role of biologic markers in the diagnosis of Alzheimer's disease. Alzheimer's & Dementia 3:4, pages 325-332.
Crossref
Crossref
Daniëlle de Jong, Berry P.H. Kremer, Marcel G.M. Olde Rikkert & Marcel M. Verbeek. (2007) Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clinical Chemical Laboratory Medicine 45:11.
Crossref
Crossref
Alessandro Stefani, Alessandro Martorana, Sergio Bernardini, Marta Panella, Flavio Mercati, Antonio Orlacchio & Mariangela Pierantozzi. (2006) CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment. Journal of the Neurological Sciences 251:1-2, pages 124-128.
Crossref
Crossref
Patrizia Formichi, Carla Battisti, Elena Radi & Antonio Federico. (2006) Cerebrospinal fluid tau, Aß, and phosphorylated tau protein for the diagnosis of Alzheimer's disease. Journal of Cellular Physiology 208:1, pages 39-46.
Crossref
Crossref
Sebastiaan Engelborghs, Karen Maertens, Ellen Vloeberghs, Tony Aerts, Nore Somers, Peter Mariën & Peter P. De Deyn. (2006) Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochemistry International 48:4, pages 286-295.
Crossref
Crossref
Miroslaw BrysLisa MosconiSusan De SantiKenneth RichMony J de Leon. (2006) Cerebrospinal fluid biomarkers for mild cognitive impairment. Aging Health 2:1, pages 111-121.
Crossref
Crossref
. (2005) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 20:8, pages 801-808.
Crossref
Crossref